Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft;Forschungsverbund Berlin E.V.
发明人:
申请号：
EP16198731.8
公开号：
EP3321264A1
申请日:
2016.11.14
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The invention relates to chemical compounds and their use as a medicament in the treatment of a disease associated with genotoxic stress-induced IKK/NF-κB (NF-kappaB) activation. The invention further relates to a pharmaceutical composition comprising a compound of the invention for the treatment of a subject afflicted by a disease associated with genotoxic stress-induced IKK/NF-κB activation.
